Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jack Roth

19PUBLICATIONS
235CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

Sort by Publication Date:
|Mar 13, 2025
Mutation of SMARCA4 Induces Cancer Cell-Intrinsic Defects in the Enhancer Landscape and Resistance to Immunotherapy.

Yawen Wang, Ismail M Meraz, Md Qudratullah

|Feb 27, 2025
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do

|Oct 09, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do

|Jul 31, 2024
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis.

Brian S White, Xing Yi Woo, Soner Koc

|Jul 08, 2024
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non-Small Cell Lung Cancer.

Haniel A Araujo, Ximo Pechuan-Jorge, Teng Zhou

|May 03, 2024
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer.

Franziska Haderk, Yu-Ting Chou, Lauren Cech

Pageof 4

Frequent Collaborators

7 joint publications

Jing Wang

6 joint publications

Jeffrey H Chuang

6 joint publications

John V Heymach

6 joint publications

Michael A Davies

6 joint publications

Meenhard Herylyn

6 joint publications

Alana Welm

6 joint publications

Yvonne A Evrard

5 joint publications

Jack Lee

5 joint publications

Stephen Swisher

5 joint publications

Sherri R Davies

Frequent Collaborators

7 joint publications

Jing Wang

6 joint publications

Jeffrey H Chuang

6 joint publications

John V Heymach

6 joint publications

Michael A Davies

Top Related Videos

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker

Published on : Sep 15, 2023

1.4K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

217
See more related videos

Top Related Videos

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker

Published on : Sep 15, 2023

1.4K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

217
See more related videos